Variant report
Variant | esv275179 |
---|---|
Chromosome Location | chr13:62809274-62818093 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs965797 | chr13:62809274-62809275 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs553330209 | chr13:62809320-62809321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367810780 | chr13:62809350-62809351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559055919 | chr13:62809373-62809374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577386998 | chr13:62809409-62809410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs965798 | chr13:62809448-62809449 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs144327752 | chr13:62809472-62809473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530314681 | chr13:62809514-62809515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs56144925 | chr13:62809549-62809550 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs192647622 | chr13:62809616-62809617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536150681 | chr13:62809635-62809636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551869920 | chr13:62809648-62809649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570423160 | chr13:62809662-62809663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531560954 | chr13:62809666-62809667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549692534 | chr13:62809670-62809671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568382207 | chr13:62809690-62809691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535743090 | chr13:62809723-62809724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563931579 | chr13:62809837-62809838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139218240 | chr13:62809840-62809841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs3223247 | chr13:62809865-62809866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73493941 | chr13:62809876-62809877 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs578257949 | chr13:62809883-62809884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200111439 | chr13:62809889-62809890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71199095 | chr13:62809892-62809893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs3030117 | chr13:62809930-62809931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147473263 | chr13:62810028-62810029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559033655 | chr13:62810062-62810063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs728545 | chr13:62810065-62810066 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs544825852 | chr13:62810066-62810067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139983483 | chr13:62810069-62810070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574841742 | chr13:62810079-62810080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542120972 | chr13:62810105-62810106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560379910 | chr13:62810145-62810146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74770124 | chr13:62810168-62810169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182179149 | chr13:62810181-62810182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186822586 | chr13:62810213-62810214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142793165 | chr13:62810307-62810308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549994120 | chr13:62810314-62810315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73493945 | chr13:62810426-62810427 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs4886401 | chr13:62810474-62810475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116434464 | chr13:62810573-62810574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113695569 | chr13:62810637-62810638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547733456 | chr13:62810683-62810684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566822959 | chr13:62810794-62810795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78133221 | chr13:62810809-62810810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113171122 | chr13:62810868-62810869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565954065 | chr13:62810877-62810878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150625637 | chr13:62810924-62810925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571401478 | chr13:62810929-62810930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34785368 | chr13:62810930-62810931 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:62809200-62811200 | Enhancers | Fetal Lung | lung |
2 | chr13:62817600-62818000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr13:62818000-62824000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |